Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 6, 2014, Pages 1545-1553

  Fukui, Yusuke ^a   Yamashita, Toru ^a   Kurata, Tomoko ^a   Sato, Kota ^a   Lukic, Violeta ^a   Hishikawa, Nozomi ^a   Deguchi, Kentaro ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

oxidative stress; peroxisome proliferator activated receptor gamma; phosphorylated synuclein; Stroke resistant spontaneously hypertensive rat; telmisartan

Indexed keywords

4 HYDROXYNONENAL; ADVANCED GLYCATION END PRODUCT; ALPHA SYNUCLEIN; TELMISARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; SYNUCLEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN CORTEX; BRAIN DAMAGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; HIPPOCAMPUS; HYPERTENSION; IMMUNOHISTOLOGY; LOW DRUG DOSE; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; BLOOD PRESSURE; BRAIN; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; WISTAR RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; BRAIN; HYPERTENSION; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; RATS, INBRED SHR; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SYNUCLEINS;

EID: 84902551255     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.12.052     Document Type: Article

References (30)

1. W. Zhang, K. Sato, and T. Hayashi et al. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain Neurol Res 26 2004 342 348
2. S. Nagotani, T. Hayashi, and K. Sato et al. Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress Stroke 36 2005 670 672
3. B. Dahlof, R.B. Devereux, and S.E. Kjeldsen et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995 1003
4. U. Rueckschloss, M.T. Quinn, and J. Holtz et al. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease Arterioscler Thromb Vasc Biol 22 2002 1845 1851
5. M. Tsuda, M. Iwai, and J.M. Li et al. Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress Hypertension 45 2005 545 551
6. J. Schrader, S. Luders, and A. Kulschewski et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors Stroke 34 2003 1699 1703
7. J. Schrader, S. Luders, and A. Kulschewski et al. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES) Stroke 36 2005 1218 1226
8. M.P. Maillard, C. Perregaux, and C. Centeno et al. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist J Pharmacol Exp Ther 302 2002 1089 1095
9. P. Gohlke, S. Weiss, and A. Jansen et al. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats J Pharmacol Exp Ther 298 2001 62 70
10. M. Mogi, J.M. Li, and K. Tsukuda et al. Telmisartan prevented cognitive decline partly due to PPAR-gamma activation Biochem Biophys Res Commun 375 2008 446 449
11. B. Wultz, T. Sagvolden, and E.I. Moser et al. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior Behav Neural Biol 53 1990 88 102
12. M. Sabbatini, A. Catalani, and C. Consoli et al. The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia? Mech Ageing Dev 123 2002 547 559
13. D. Sanz-Rosa, M.P. Oubina, and E. Cediel et al. Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences Antioxid Redox Signal 7 2005 1294 1301
14. Y. Kumai, H. Ooboshi, and T. Ago et al. Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure Exp Neurol 210 2008 441 448
15. M. Suematsu, H. Suzuki, and F.A. Delano et al. The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis Microcirculation 9 2002 259 276
16. K. Ikeda, A. Kitamura, and H. Machida et al. Effect of Undaria pinnatifida (Wakame) on the development of cerebrovascular diseases in stroke-prone spontaneously hypertensive rats Clin Exp Pharmacol Physiol 30 2003 44 48
17. K.Y. Chau, H.L. Ching, and A.H. Schapira et al. Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis J Neurochem 110 2009 1005 1013
18. W. Wienen, and H.J. Schierok Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats J Renin Angiotensin Aldosterone Syst 2 2001 123 128
19. A. Burlacu, V. Jinga, and A.V. Gafencu et al. Severity of oxidative stress generates different mechanisms of endothelial cell death Cell Tissue Res 306 2001 409 416
20. S.P. Didion, and F.M. Faraci Angiotensin II produces superoxide-mediated impairment of endothelial function in cerebral arterioles Stroke 34 2003 2038 2042
21. I.R. Hanna, Y. Taniyama, and K. Szocs et al. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling Antioxid Redox Signal 4 2002 899 914
22. S. Rajagopalan, S. Kurz, and T. Munzel et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone J Clin Invest 97 1996 1916 1923
23. B.I. Giasson, J.E. Duda, and I.V. Murray et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 2000 985 989
24. H. Fujiwara, M. Hasegawa, and N. Dohmae et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions Nat Cell Biol 4 2002 160 164
25. N. Sugeno, A. Takeda, and T. Hasegawa et al. Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death J Biol Chem 283 2008 23179 23188
26. S.C. Benson, H.A. Pershadsingh, and C.I. Ho et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 2004 993 1002
27. M.L. Modrick, D.A. Kinzenbaw, and Y. Chu et al. Peroxisome proliferator-activated receptor-gamma protects against vascular aging Am J Physiol Regul Integr Comp Physiol 302 2012 R1184 R1190
28. T. Kurihara, Y. Ozawa, and K. Shinoda et al. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation Invest Ophthalmol Vis Sci 47 2006 5545 5552
29. M.S. Ola, M.M. Ahmed, and H.M. Abuohashish et al. Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin- induced diabetic rats Neurochem Res 38 2013 1572 1579
30. L.J. Min, M. Mogi, and M. Shudou et al. Peroxisome proliferator-activated receptor-gamma activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice Hypertension 59 2012 1079 1088